Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Celularity Q2 EPS $0.32

Celularity Q2 EPS $0.32

Celularity (NASDAQ:CELU) reported quarterly earnings of $0.32 per share.

byBill Haddad

August 9, 2022

1 minute read

Celularity (NASDAQ:CELU) reported quarterly earnings of $0.32 per share.

Philip Morris International FY23 Outlook: Adj Diluted EPS $6.10 – $6.22 vs. $6.34 Estimate, EPS $5.88 – $6.00, Organic Revenue Growth 7% – 8.5%

By Benzinga Newsdesk

April 20, 7:10 AM

2023 FULL-YEAR FORECAST Full-Year 2023 Forecast 2022 Growth Reported Diluted EPS$5.88-$6.00$

Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday?

By Vandana Singh

June 3, 1:55 PM

Arrowhead Pharmaceuticals announced Phase 3 PALISADE study results showing significant triglyceride reduction in familial chylomicronemia syndrome patients treated with plozasiran.

ARWR

Morgan Stanley, Snowflake And 2 Other Stocks Insiders Are Selling

By Avi Kapoor

January 26, 8:58 AM

The Nasdaq 100 closed higher by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.

ABNB

Tesla Representatives, Indian Minister Reportedly Held Discreet Discussions On Setting Up EV Factory

By Arpit Nayak

August 4, 4:05 AM

This story was first published on the Benzinga India portal.

TSLA

Celularity Q2 EPS $0.32

Related Posts

Philip Morris International FY23 Outlook: Adj Diluted EPS $6.10 – $6.22 vs. $6.34 Estimate, EPS $5.88 – $6.00, Organic Revenue Growth 7% – 8.5%

Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday?

Morgan Stanley, Snowflake And 2 Other Stocks Insiders Are Selling

Tesla Representatives, Indian Minister Reportedly Held Discreet Discussions On Setting Up EV Factory